Literature DB >> 28674989

Leukodystrophy: Basic and Clinical.

Gerald V Raymond1,2.   

Abstract

Leukodystrophies are serious, progressive, genetic disorders of CNS myelin. They may result from abnormalities of the oligodendrocyte or any of the other of myriad of supporting cells or tissues. With recent developments in neuroimaging, their presence is becoming increasingly noted even in situations where they were not suspected. More importantly, new genetic tools have improved our ability to diagnose. An understanding of pathogenesis is still evolving, but it is expected that this will assist in developing targeted therapies for these devastating disorders.

Entities:  

Keywords:  Adrenoleukodystrophy; Alexander disease; Globoid cell leukodystrophy; Leukodystrophy; Myelin

Mesh:

Year:  2017        PMID: 28674989     DOI: 10.1007/978-3-319-57193-5_14

Source DB:  PubMed          Journal:  Adv Neurobiol


  3 in total

1.  Intracerebral lentiviral ABCD1 gene therapy in an early disease onset ALD mouse model.

Authors:  Jie Gong; Yunyun Liu; Tsai-Hua Chung; Liu Xu; Troy C Lund; Lung-Ji Chang
Journal:  Gene Ther       Date:  2022-07-06       Impact factor: 5.250

Review 2.  Ceramide and Sphingosine Regulation of Myelinogenesis: Targeting Serine Palmitoyltransferase Using microRNA in Multiple Sclerosis.

Authors:  Somsankar Dasgupta; Swapan K Ray
Journal:  Int J Mol Sci       Date:  2019-10-11       Impact factor: 5.923

3.  Diverse Biological Functions of Sphingolipids in the CNS: Ceramide and Sphingosine Regulate Myelination in Developing Brain but Stimulate Demyelination during Pathogenesis of Multiple Sclerosis.

Authors:  Somsankar Dasgupta; Swapan K Ray
Journal:  J Neurol Psychol       Date:  2017-12-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.